Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of CD-004 for chemotherapy-related side effects in adults with breast cancer
MOH_2021-03-11_009826Phase 2Not yet recruiting
- Sponsor
- Canndoc
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chemotherapy-induced nausea and vomiting (CINV) and breast cancer comparing CD-004 with Placebo (2 arms). Planned start Dec 2019; status: not yet recruiting.
02
Drugs
CD004
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)breast cancer
Beyond the preview
Go deeper on MOH_2021-03-11_009826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-03-11_009826.